BRIEF

on ABIONYX (EPA:ABNX)

ABIONYX Successfully Completes €3.4 Million Capital Increase

Stock price chart of ABIONYX (EPA:ABNX) showing fluctuations.

ABIONYX Pharma has conducted a successful capital increase, raising approximately €3.4 million. This increase was achieved through the issue of 2,472,000 new shares, each accompanied by a warrant. The subscription price was set at €1.37 per share with a warrant.

Each warrant allows the holder to subscribe for a new share at a price of €3, with an exercise period of three years. This fundraising aims to bolster the company's cash position and support its development efforts, particularly in sepsis and the U.S. market.

The shares issued will constitute about 7.62% of the current share capital. These shares carry dividend rights and are assimilated to existing shares, trading on Euronext. The operation, authorized by the Board of Directors, does not require an AMF-approved prospectus.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all ABIONYX news